<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21837" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Fluid Resuscitation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wallace</surname>
            <given-names>Heather A.</given-names>
          </name>
          <aff>Old Dominion University, Johns Hopkins University, Baylor University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Regunath</surname>
            <given-names>Hariharan</given-names>
          </name>
          <aff>University of Maryland - Baltimore Washington Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Heather Wallace declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hariharan Regunath declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21837.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The primary role of fluid resuscitation is to maintain organ perfusion (hemodynamics) and substrate (oxygen, electrolytes, among others) delivery through the administration of fluid and electrolytes. An enteral route can be used; however, when oral intake is not possible, clinicians can replace fluid losses by intravenous (IV) administration. This activity describes the types of fluids, indications, contraindications and highlights the role of the interprofessional team in monitoring the patients during resuscitation which will assist in improving outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify conditions where fluid resuscitation is recommended.</p></list-item><list-item><p>Describe the types of fluids used to resuscitate trauma patients.</p></list-item><list-item><p>Summarize the complications of inappropriate fluid resuscitation.</p></list-item><list-item><p>Explain the importance of collaboration and communication among the interprofessional team to ensure appropriate fluid resuscitation of patients in shock and to enhance outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21837&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21837">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21837.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The primary role of fluid resuscitation is to maintain organ perfusion (hemodynamics) and&#x000a0;substrate&#x000a0;(oxygen, electrolytes, among others) delivery through the administration of fluid and electrolytes. An enteral route can be used; however, when oral intake is not possible, clinicians can replace fluid losses by intravenous (IV) administration.<xref ref-type="bibr" rid="article-21837.r1">[1]</xref></p>
      </sec>
      <sec id="article-21837.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Body&#x000a0;fluids are distributed into intracellular and extracellular compartments. Intracellular compartment contributes to&#x000a0;most total body water. Extracellular fluids are within the interstitial, intravascular, and trans-cellular spaces.<xref ref-type="bibr" rid="article-21837.r2">[2]</xref>&#x000a0;Predominant electrolytes in body fluids are sodium and potassium, where sodium is the dominant cation in the extracellular fluid and potassium is the dominant cation in the intracellular fluid. Sodium and magnesium are the other minor cations in the intracellular fluids and are electrochemically balanced by phosphate, sulfate, and bicarbonate anions. Calcium and magnesium are the other cations found in minor concentrations in the extracellular fluid, and they&#x000a0;are balanced by chloride, bicarbonate, phosphate, and sulfate anions.<xref ref-type="bibr" rid="article-21837.r2">[2]</xref></p>
      </sec>
      <sec id="article-21837.s4" sec-type="Indications">
        <title>Indications</title>
        <p>
<bold>Trauma</bold>
</p>
        <p>Trauma is the number one cause of death in the United States for individuals between 1 and 44 years of age. Among them, hemorrhagic shock is the primary cause of death for 30% to 40% in the first 24 hours following injury. Loss of blood triggers a compensatory hemodynamic response to restore volume. The compensatory mechanisms click in when there is acute blood loss of more than 5% to 10%. Blood losses of greater than 20% will require fluid resuscitation to support the continued delivery of oxygen to vital organs.<xref ref-type="bibr" rid="article-21837.r3">[3]</xref></p>
        <p>Trauma and acute blood loss trigger compensatory mechanisms aimed at restoring volume deficits to maintain adequate perfusion of vital organs. Trans-capillary refill occurs first and involves the shift of fluid from the interstitial space into the intravascular space secondary to increased capillary permeability and decreased plasma colloid osmotic pressure. The resultant effect is the sequestration of about 1 liter of fluid into intravascular spaces. Activation of the renin-angiotensin-aldosterone system occurs next, activated by the reduction in&#x000a0;renal perfusion and causing sodium and water retention by the kidneys.</p>
        <p>The overall goal is to replace the fluid lost from the interstitial compartment to the intravascular spaces. But one&#x000a0;must exercise caution, because an aggressive&#x000a0;large volume fluid resuscitation may lead to hypothermia, acidosis, and coagulopathy.<xref ref-type="bibr" rid="article-21837.r3">[3]</xref><xref ref-type="bibr" rid="article-21837.r4">[4]</xref>&#x000a0;Typical indications for resuscitation are a systolic blood pressure of less than 80 to 85 mm Hg or one that is rapidly decreasing and/or a decline in mental status without evidence of head trauma.<xref ref-type="bibr" rid="article-21837.r4">[4]</xref></p>
        <p>Two major types of fluids used for resuscitation are colloids which specifically expand the intravascular volume and crystalloids, which briefly expand the intravascular volume and quickly re-distribute into the interstitial compartment. For resuscitation, crystalloids&#x000a0;are given as 1- to 2-liter bolus in patients with hemorrhagic shock. However, recent studies using colloids favor permissive hypotension. For example, in patients with penetrating trauma, aggressive fluid resuscitation may exacerbate bleeding, so the emphasis is on administering small boluses of fluid (250mL) allowing a low systolic blood pressure equal to&#x000a0; 90 mm Hg or mean blood pressure equal to 50 mm Hg until one achieves sustained hemorrhagic control. This strategy has been shown to improve survival&#x000a0;and&#x000a0;reduce the amount of fluid replaced.</p>
        <p>It is important to remember that it is only safe to allow low blood pressures&#x000a0;when there is good clinical evidence of adequate organ perfusion indicated through&#x000a0;adequate urine output and&#x000a0;mental status.<xref ref-type="bibr" rid="article-21837.r4">[4]</xref>&#x000a0;Crystalloids should ideally serve as a bridge to maintain perfusion until&#x000a0;blood products are available&#x000a0;in hemorrhagic shock. Hence, one should consider limited 500-ml bolus doses in patients without or impending shock until&#x000a0;blood products become available.<xref ref-type="bibr" rid="article-21837.r5">[5]</xref></p>
        <p>
<bold>Sepsis</bold>
</p>
        <p>Sepsis is a leading cause of morbidity and mortality in critically ill patients with mortality ranging between 20% to 45%. Uncontrolled inflammation,&#x000a0;tissue hypoperfusion, microvascular and micro-cellular level abnormalities, and dysfunction are critical determinants in the progression toward multiple organ failure, which predict poor outcomes. Septic shock is defined as refractory hypotension that results from a systemic inflammatory response syndrome (SIRS) caused by or suspected to be from an infection.<xref ref-type="bibr" rid="article-21837.r6">[6]</xref></p>
        <p>The key characteristic of septic shock is systemic vasodilation which results in hypovolemia, decreased tissue perfusion and decreased oxygen delivery. The main aim of fluid resuscitation&#x000a0;is to restore hemodynamics to optimize tissue perfusion and ultimately the tissue oxygen delivery.<xref ref-type="bibr" rid="article-21837.r6">[6]</xref></p>
        <p>For resuscitation, one should give crystalloids at a dose of 30 mL/kg of ideal body weight as early as possible,&#x000a0;typically within the first 3 hours. Central venous pressure (CVP), mean arterial pressure (MAP), and central venous oxygen saturation (ScvO2) can guide fluid resuscitation if shock (mean arterial blood pressure - MAP less than 65 mm Hg or lactate&#x000a0;level greater than 4.0 mmol/L) persist. Within the first 6 hours of initial resuscitation, one should aim for a CVP target between 8 to 12 mm Hg in spontaneously breathing patients and CVP between 12 to 15mm Hg in mechanically-ventilated patients; a MAP greater than&#x000a0;65 mm Hg and ScvO2 greater than 70% have been shown to improve mortality. Lactate level should be monitored during resuscitation since increases may reflect a decrease in tissue perfusion.<xref ref-type="bibr" rid="article-21837.r6">[6]</xref></p>
      </sec>
      <sec id="article-21837.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>0.9% saline should be used with caution in patients with subarachnoid hemorrhage or postoperative acute kidney injury (AKI) as these conditions can themselves cause alterations in serum sodium concentration (hypo or hypernatremia).<xref ref-type="bibr" rid="article-21837.r7">[7]</xref><xref ref-type="bibr" rid="article-21837.r8">[8]</xref></p>
        <p>Colloids such as&#x000a0;hydroxyethyl&#x000a0;starch (HES) should be avoided in septic shock because of their adverse effects on coagulation and renal function. A blinded, randomized, controlled trial of 800 severely septic intensive care unit (ICU) patients in Scandinavia found that 6% HES&#x000a0;is&#x000a0;associated with an increase in death at 90 days compared to Ringer&#x02019;s acetate.<xref ref-type="bibr" rid="article-21837.r7">[7]</xref><xref ref-type="bibr" rid="article-21837.r9">[9]</xref><xref ref-type="bibr" rid="article-21837.r8">[8]</xref></p>
        <p>Intravenous albumin is contraindicated in patients with traumatic brain injury.<xref ref-type="bibr" rid="article-21837.r10">[10]</xref></p>
      </sec>
      <sec id="article-21837.s6" sec-type="Complications">
        <title>Complications</title>
        <p>Large amounts of intravenous fluids can cause hypervolemia and potentially electrolyte imbalance. In septic shock, overzealous use of intravenous fluids for a prolonged period&#x000a0;can cumulatively increase the total body water, especially in patients with compromised renal, cardiac or hepatic&#x000a0;function. This excess free water often accumulates in the extravascular lung (pulmonary edema) and subcutaneous&#x000a0;tissues (pedal or sacral edema) and poses problems during recovery, for example, failure to wean from the ventilator and muscle weakness, both of which will cause prolongation&#x000a0;of hospital stay and increase the associated risk of nosocomial complications. A 0.9% saline causes hyperchloremic acidosis following excess use and is associated with nephrotoxicity.</p>
      </sec>
      <sec id="article-21837.s7" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The goal of fluid resuscitation is to maintain homeostasis. This goal requires not only administering enough fluid volume to optimize hemodynamics and perfusion but also to maintain electrolyte balances. Maintenance fluids are given for select indications such as prolonged fasting for planned surgical procedures and conditions limiting oral fluid intake (severe nausea, vomiting, diarrhea). Maintenance fluid volume requirements in children is&#x000a0;based on body weight with 100 ml/kg per day for the first 0 to 10 kg, an additional 50 ml/kg per day for the next 10 to 20 kg, and 20 ml/kg/day for weight greater than 20 kg. In adults, maintenance fluid is typically 35 ml/kg per day. One&#x000a0;must also consider electrolyte replacement besides maintaining the required fluid volumes. Sodium is required&#x000a0;at a concentration of&#x000a0;1 to 2 mEq/kg per day and potassium is replaced at a rate of 0.5 to 1 mEq/kg per day.<xref ref-type="bibr" rid="article-21837.r2">[2]</xref><xref ref-type="bibr" rid="article-21837.r1">[1]</xref></p>
      </sec>
      <sec id="article-21837.s8" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Additional components for consideration in trauma resuscitation are to minimize the use of crystalloid fluid due to the potential for increasing the inflammatory response. Studies have also shown early use of blood products improve outcomes in trauma patients.<xref ref-type="bibr" rid="article-21837.r4">[4]</xref>&#x000a0;The PROPPR (Pragmatic Randomized Optimal Platelet and Plasma Ratios, 2016) study assessed 1:1:1 versus 1:1:2 ratios of plasma to platelets to red blood cells in severely injured patients and found that there were earlier hemorrhage control and decreased deaths secondary to exsanguination in the first 24 hours in the 1:1:1 group.<xref ref-type="bibr" rid="article-21837.r4">[4]</xref>&#x000a0;In pediatric patients,&#x000a0;fluid resuscitation is indicated in the presence of hemorrhagic shock. An initial bolus of 20 mL/kg of either warmed 0.9% saline or&#x000a0;lactated ringers is given. A repeat bolus of 20 mL/kg can be given if there is a transient or no response to initial bolus and then switch to resuscitation with blood products (10 mL/kg). There is no evidence to support permissive hypotension or damage control resuscitation in pediatric patients.<xref ref-type="bibr" rid="article-21837.r4">[4]</xref><xref ref-type="bibr" rid="article-21837.r2">[2]</xref></p>
        <p>Choices of fluid for septic shock resuscitation vary. Crystalloids are the fluids of choice in septic shock resuscitation, but no crystalloid solution is specifically favorable over the other due to a lack of evidence of direct comparisons in septic shock patients.<xref ref-type="bibr" rid="article-21837.r2">[2]</xref><xref ref-type="bibr" rid="article-21837.r1">[1]</xref><xref ref-type="bibr" rid="article-21837.r7">[7]</xref>&#x000a0;The Crystalloid versus Hydroxyethyl Starch&#x000a0;Trial (CHEST) which was a blinded, randomized, controlled trial of 7000 ICU patients&#x000a0;found that 6% HES was not associated with a significant increase in death at 90 days but was&#x000a0;associated with an increase in the renal-replacement therapy rate. The Saline versus Albumin Fluid Evaluation (SAFE) Trial in Australia and New Zealand found a correlation between albumin resuscitation and a decrease in the adjusted risk of death at 28 days in septic patients.<xref ref-type="bibr" rid="article-21837.r8">[8]</xref><xref ref-type="bibr" rid="article-21837.r11">[11]</xref></p>
      </sec>
      <sec id="article-21837.s9">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21837&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21837">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21837/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21837">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21837.s10">
        <title>References</title>
        <ref id="article-21837.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cantle</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Cotton</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Balanced Resuscitation in Trauma Management.</article-title>
            <source>Surg Clin North Am</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>97</volume>
            <issue>5</issue>
            <fpage>999</fpage>
            <page-range>999-1014</page-range>
            <pub-id pub-id-type="pmid">28958369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21837.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wise</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Faurie</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Malbrain</surname>
                <given-names>MLNG</given-names>
              </name>
              <name>
                <surname>Hodgson</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Strategies for Intravenous Fluid Resuscitation in Trauma Patients.</article-title>
            <source>World J Surg</source>
            <year>2017</year>
            <month>May</month>
            <volume>41</volume>
            <issue>5</issue>
            <fpage>1170</fpage>
            <page-range>1170-1183</page-range>
            <pub-id pub-id-type="pmid">28058475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21837.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carrick</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Leonard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Slone</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Mains</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Bar-Or</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Hypotensive Resuscitation among Trauma Patients.</article-title>
            <source>Biomed Res Int</source>
            <year>2016</year>
            <volume>2016</volume>
            <fpage>8901938</fpage>
            <pub-id pub-id-type="pmid">27595109</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21837.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simmons</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Acute traumatic coagulopathy: pathophysiology and resuscitation.</article-title>
            <source>Br J Anaesth</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>117</volume>
            <issue>suppl 3</issue>
            <fpage>iii31</fpage>
            <page-range>iii31-iii43</page-range>
            <pub-id pub-id-type="pmid">27940454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21837.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Minei</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Maier</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Billiar</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Peitzman</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Cuschieri</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sperry</surname>
                <given-names>JL</given-names>
              </name>
              <collab>Inflammation and the Host Response to Injury Investigators</collab>
            </person-group>
            <article-title>Goal-directed resuscitation in the prehospital setting: a propensity-adjusted analysis.</article-title>
            <source>J Trauma Acute Care Surg</source>
            <year>2013</year>
            <month>May</month>
            <volume>74</volume>
            <issue>5</issue>
            <fpage>1207</fpage>
            <page-range>1207-12; discussion 1212-4</page-range>
            <pub-id pub-id-type="pmid">23609269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21837.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rhodes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Alhazzani</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sevransky</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Sprung</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Nunnally</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Rochwerg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rubenfeld</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Annane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Beale</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Bellinghan</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Chiche</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Coopersmith</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De Backer</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Fujishima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gerlach</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hidalgo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hollenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Karnad</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Kleinpell</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lisboa</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Machado</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Mazuski</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McIntyre</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>McLean</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Myburgh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Navalesi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nishida</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Osborn</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Perner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Plunkett</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Ranieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schorr</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Seckel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Seymour</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Shieh</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shukri</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>SQ</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Townsend</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Van der Poll</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Wiersinga</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Dellinger</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.</article-title>
            <source>Intensive Care Med</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>304</fpage>
            <page-range>304-377</page-range>
            <pub-id pub-id-type="pmid">28101605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21837.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bossers</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Koning</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Choice of fluid type: physiological concepts and perioperative indications.</article-title>
            <source>Br J Anaesth</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>120</volume>
            <issue>2</issue>
            <fpage>384</fpage>
            <page-range>384-396</page-range>
            <pub-id pub-id-type="pmid">29406187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21837.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anthon</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Haase</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hjortrup</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wetterslev</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Perner</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis.</article-title>
            <source>Acta Anaesthesiol Scand</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>61</volume>
            <issue>8</issue>
            <fpage>904</fpage>
            <page-range>904-913</page-range>
            <pub-id pub-id-type="pmid">28653377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21837.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malbrain</surname>
                <given-names>MLNG</given-names>
              </name>
              <name>
                <surname>Van Regenmortel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Saugel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>De Tavernier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Van Gaal</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Joannes-Boyau</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Teboul</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Mythen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Monnet</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Principles of fluid management and stewardship in septic shock: it is time to consider the four D's and the four phases of fluid therapy.</article-title>
            <source>Ann Intensive Care</source>
            <year>2018</year>
            <month>May</month>
            <day>22</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>66</fpage>
            <pub-id pub-id-type="pmid">29789983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21837.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>SAFE Study Investigators</collab>
              <collab>Australian and New Zealand Intensive Care Society Clinical Trials Group</collab>
              <collab>Australian Red Cross Blood Service</collab>
              <collab>George Institute for International Health</collab>
              <name>
                <surname>Myburgh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Finfer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bellomo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bishop</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kai Lo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vallance</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Saline or albumin for fluid resuscitation in patients with traumatic brain injury.</article-title>
            <source>N Engl J Med</source>
            <year>2007</year>
            <month>Aug</month>
            <day>30</day>
            <volume>357</volume>
            <issue>9</issue>
            <fpage>874</fpage>
            <page-range>874-84</page-range>
            <pub-id pub-id-type="pmid">17761591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21837.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <collab>Crystalloid versus Hydroxyethyl Starch Trial (CHEST) Management Committee</collab>
            <article-title>The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality.</article-title>
            <source>Intensive Care Med</source>
            <year>2011</year>
            <month>May</month>
            <volume>37</volume>
            <issue>5</issue>
            <fpage>816</fpage>
            <page-range>816-23</page-range>
            <pub-id pub-id-type="pmid">21308360</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
